Search - tctmd.com

Displaying 101 - 120 of 3795

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Evolocumab Wins for Primary Prevention in VESALIUS-CV

L.A. McKeown

October 03, 2025

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

News Industry News

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

September 15, 2025

News Conference News ESC 2025

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

Caitlin E. Cox

September 08, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Conference News ESC 2025

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

Caitlin E. Cox

September 05, 2025

News Conference News ESC 2025

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

Michael O'Riordan

September 04, 2025

News Conference News ESC 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

Todd Neale

September 01, 2025

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Conference News ESC 2025

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Caitlin E. Cox

August 29, 2025

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

Michael O'Riordan

August 26, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Conference News SCCT 2025

CT-Guided PCI Coming Soon to a Cath Lab Near You—If Not There Already

Yael L. Maxwell

July 31, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

News Daily News

Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say

L.A. McKeown

July 22, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

Advertisement

What’s Going to Be Hot at TCT 2025

Evolocumab Wins for Primary Prevention in VESALIUS-CV

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Evolocumab Gains Expanded Indication for Primary Prevention

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

CT-Guided PCI Coming Soon to a Cath Lab Near You—If Not There Already

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content